These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10105708)

  • 1. A system for monitoring and dispensing epoetin.
    Cohen MR
    Hosp Pharm; 1990 Aug; 25(8):745-6. PubMed ID: 10105708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous quality assurance monitoring by staff pharmacists.
    Spradling GF
    Hosp Pharm; 1990 Nov; 25(11):1021-4, 1027. PubMed ID: 10108872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint pharmacy/nursing procedure for monitoring unit dose distribution and unadministered doses.
    Dahl FC; Conway MF; Henderson CM
    Hosp Pharm; 1986 Sep; 21(9):857-60. PubMed ID: 10278987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of a quality assurance instrument for a renal dialysis unit.
    Molzahn-Yanitski AE
    Nephrol Nurse; 1983; 5(6):8-12. PubMed ID: 6560249
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug usage evaluation of epoetin in chronic renal failure.
    Mason NA; Iacobellis DP
    Hosp Formul; 1992 Sep; 27(9):928-32, 937-8. PubMed ID: 10121421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consultant evaluation of a hospital medication system: implementation and evaluation of the new system.
    Barker KN; Harris JA; Webster DB; Stringer JF; Pearson RE; Mikeal RL; Glotzhober GR; Miller GJ
    Am J Hosp Pharm; 1984 Oct; 41(10):2022-9. PubMed ID: 6496490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients.
    Kaufman JS; Reda DJ; Fye CL; Goldfarb DS; Henderson WG; Kleinman JG; Vaamonde CA
    N Engl J Med; 1998 Aug; 339(9):578-83. PubMed ID: 9718376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An educational tool for the care of the hemodialysis patient admitted to an acute care hospital.
    Deschenes D
    CANNT J; 2001; 11(4):24-9; quiz 30-2, 35-41; quiz 41--3. PubMed ID: 11885347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin.
    Jones EH
    Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S20-3. PubMed ID: 2690606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missing medications in a unit-dose system: quality assurance.
    Grabowski B
    Hosp Pharm; 1987 Jul; 22(7):679-80. PubMed ID: 10282684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quality assurance program for clinical pharmacy services provided to a long-term care unit in a community hospital.
    Edlund M; Harwood D
    Can J Hosp Pharm; 1986 Oct; 39(5):119-24. PubMed ID: 10311707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Source of missing doses in a decentralized unit dose system: a quality assurance review.
    Churchill WW; Gavin TJ; Souney PF; Stachowski JS
    Hosp Pharm; 1988 May; 23(5):453-6. PubMed ID: 10287637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a modified decentralized drug distribution system with the use of master medication carts.
    Hand DL; Pang FJ
    Hosp Pharm; 1981 Aug; 16(8):414, 417-8. PubMed ID: 10252374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance of data collection in an aminoglycoside dosing service.
    Lew KH; Malyuk DL
    Can J Hosp Pharm; 1991 Oct; 44(5):239-43. PubMed ID: 10115577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines for the treatment of anemia in chronic renal failure].
    Triolo G;
    G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoetin: human recombinant erythropoietin.
    Flaharty KK; Grimm AM; Vlasses PH
    Clin Pharm; 1989 Nov; 8(11):769-82. PubMed ID: 2680241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.